Facebook Twitter
Print

S20: Challenging Clinical Dilemmas in Patient-centered Integrative Oncology: A Hands-on Workshop for Clinicians and Patient-centered Researchers

10:30 - 12:00, Orchid CD, Terrace Level

Eran Ben-Arye (1), Alfred Längler (2), George Lewith (3), Thomas Breitkreuz (4), Elio Rossi (5), Richard T. Lee (6)

(1) Haifa and Western Galilee Oncology Service, Lin Medical center, Clalit Health Services, Haifa and Western Galilee District, Israel 
(2) University of Witten/Herdecke, Faculty of Health , Institute for integrative medicine, Germany
(3) University of Southampton, Hampshire, England, UK 
(4) Paracelsus-Krankenhaus Unterlengenhardt e.V., Bad Liebenzell, Germany
(5) Clinic of Complementary Medicine and Diet in Oncology, Lucca Provincial Hospital, Tuscan Regional Network for Integrative Medicine, Italy 
(6) Integrative Medicine Center, MD Anderson Cancer Center, Houston, Texas, USA

                                                    

During the past decade a number of integrative oncology programs have emerged within the walls of leading oncology centers worldwide, primarily in a supportive and palliative setting. Yet despite the fact that integrative oncology is the most-researched field of integrative medicine, with the largest number of publications in highly ranked journals, a large segment of daily clinical practice remains within the “gray” area of as-yet non-rigorously researched practices. As a result of this uncertainty, integrative practitioners and oncologists often find themselves in a clinical quandary, especially in cases where individualized therapies are use to address patient concerns and quality-of-life issues.


The proposed workshop is intended for integrative oncology practitioners and researchers with an interest in patient-centered therapies with an individualized treatment plan. The goals of this workshop include the provision of practical skills for the management of clinical dilemmas in integrative oncology, and to examine the potential strengths of the multi-disciplinary integrative team, in order to devise a safe and efficacious treatment strategy for the patient.   


The workshop will present situations focusing on three major clinical dilemmas which, at present, lack sufficient research for guideline-directed decision-making:  
1. Treatment of a patient with chemotherapy-induced thrombocytopenia referred by the treating oncologist with a risk of cessation of chemotherapy with disease progression. 
2. Treatment of advanced cancer-related fatigue; discussing the current research, and designing a patient-centered therapeutic approach.
3. Treatment of chemotherapy-induced peripheral neuropathy: discussing the current research, and designing a patient-centered therapeutic approach.  
Moderators and participants from international integrative oncology practices will be invited to participate in the workshop. The workshop should lead to international collaborative projects which will continue to grapple with the issues raised.